Gene · 4440
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plus-strand RNA viruses hijack Musashi homolog 1 to shield viral RNA from cytoplasmic ribonuclease degradation. | J Virol | 2025 | 39936918 | PubTator, text mining | PubMed |
| Lobaric acid suppresses the stemness potential of colorectal cancer cells through mTOR/AKT. | Biofactors | 2025 | 39874220 | PubTator, text mining | PubMed |
| Resveratrol Inhibits Colorectal Cancer Cell Tumor Property by Activating the miR-769-5p/MSI1 Pathway. | Mol Biotechnol | 2025 | 38771419 | PubTator, text mining | PubMed |
| Viral RNA Interactome: The Ultimate Researcher's Guide to RNA-Protein Interactions. | Viruses | 2024 | 39599817 | PubTator, text mining | PubMed |
| A Snapshot of Early Transcriptional Changes Accompanying the Pro-Neural Phenotype Switch by NGN2, ASCL1, SOX2, and MSI1 in Human Fibroblasts: An RNA-Seq Study. | Int J Mol Sci | 2024 | 39596450 | PubTator, text mining | PubMed |
| Characterization of E-Cadherin, SSEA-1, MSI-1, and SOX-2 Expression and Their Association with Pale Cells in Adenomyosis. | Biomolecules | 2024 | 39595532 | PubTator, text mining | PubMed |
| Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II Randomized Controlled Trial. | Anticancer Res | 2024 | 39477312 | PubTator, text mining | PubMed |
| Altered PLCβ/IP3/Ca2+ Signaling Pathway Activated by GPRCs in Olfactory Neuronal Precursor Cells Derived from Patients Diagnosed with Schizophrenia. | Biomedicines | 2024 | 39457654 | PubTator, text mining | PubMed |
| Unraveling the Bivalent and Rapid Interactions Between a Multivalent RNA Recognition Motif and RNA: A Kinetic Approach. | Biochemistry | 2024 | 39397705 | PubTator, text mining | PubMed |
| Probing the orthogonality and robustness of the mammalian RNA-binding protein Musashi-1 in Escherichia coli. | J Biol Eng | 2024 | 39350178 | PubTator, text mining | PubMed |
| Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer. | Oncogene | 2024 | 39164523 | PubTator, text mining | PubMed |
| [Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39103266 | PubTator, text mining | PubMed |
| A novel interaction between the 5' untranslated region of the Chikungunya virus genome and Musashi RNA binding protein is essential for efficient virus genome replication. | Nucleic Acids Res | 2024 | 39087525 | PubTator, text mining | PubMed |
| Comparative Assessment of miR-185-5p and miR-191-5p Expression: From Normal Endometrium to High-Grade Endometrial Cancer. | Cells | 2024 | 38994952 | PubTator, text mining | PubMed |
| Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer. | Exp Hematol | 2024 | 38969020 | PubTator, text mining | PubMed |
| Integrin β3 Reprogramming Stemness in HER2-Positive Breast Cancer Cell Lines. | Biology (Basel) | 2024 | 38927308 | PubTator, text mining | PubMed |
| The Musashi-1-type 2 deiodinase pathway regulates astrocyte proliferation. | J Biol Chem | 2024 | 38879014 | PubTator, text mining | PubMed |
| Thyroid hormone enhances efficacy of cisplatin in lung cancer patients via down-regulating GLUT1 expression and reversing the Warburg effect. | Mitochondrion | 2024 | 38876298 | PubTator, text mining | PubMed |
| MSC Promotes the Secretion of Exosomal lncRNA KLF3-AS1 to Regulate Sphk1 Through YY1-Musashi-1 Axis and Improve Cerebral Ischemia-Reperfusion Injury. | Mol Neurobiol | 2024 | 38735900 | PubTator, text mining | PubMed |
| Correction: Circ_0055625 knockdown inhibits tumorigenesis and improves radiosensitivity by regulating miR-338-3p/MSI1 axis in colon cancer. | World J Surg Oncol | 2024 | 38671499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4440/papers?page=3